Aardvark Therapeutics Inc (AARD)

02:54 AM

Will Aardvark Therapeutics Inc. stock benefit from commodity pricesMarket Growth Report & Daily Market Momentum Tracking - Newser

02:54 AM

Dec 04, 2025

Raymond James Financial Begins Coverage on Aardvark Therapeutics (NASDAQ:AARD) - MarketBeat

Dec 04, 2025

Dec 04, 2025

Individual investors among Aardvark Therapeutics, Inc.'s (NASDAQ:AARD) largest shareholders, saw gain in holdings value after stock jumped 23% last week - simplywall.st

Dec 04, 2025

Dec 03, 2025

AARD: Phase 3 Prader-Willi data expected Q3 2026; obesity program readout by end of next year - TradingView

Dec 03, 2025

Dec 02, 2025

Aardvark Therapeutics initiated with a Strong Buy at Raymond James - TipRanks

Dec 02, 2025

Dec 02, 2025

Raymond James initiates coverage on Aardvark Therapeutics stock with Strong Buy - Investing.com UK

Dec 02, 2025

Nov 30, 2025

Aardvark Therapeutics Hosts Investor Webinar on Drug Programs - MSN

Nov 30, 2025

Nov 30, 2025

Analysts Set Aardvark Therapeutics, Inc. (NASDAQ:AARD) PT at $30.63 - Defense World

Nov 30, 2025

Nov 26, 2025

What risks investors should watch in Aardvark Therapeutics Inc. stockEarnings Trend Report & Real-Time Chart Breakout Alerts - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

Aardvark Therapeutics to Present at Upcoming Investor Conferences in December - The Manila Times

Nov 25, 2025

Nov 19, 2025

Why Aardvark Therapeutics Inc. stock is seen as undervalued2025 Big Picture & Fast Gain Swing Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Aardvark Therapeutics Inc. stock attract ESG investorsJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

From HERO To POWER: AARD Charts Bold Course In Obesity And Rare Disease Trials - RTTNews

Nov 18, 2025

Nov 18, 2025

Real time social sentiment graph for Aardvark Therapeutics Inc. - newser.com

Nov 18, 2025

Nov 17, 2025

Aardvark Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 17, 2025

Nov 16, 2025

Is Aardvark Therapeutics Inc. forming a reversal patternGold Moves & Reliable Entry Point Alerts - newser.com

Nov 16, 2025

Nov 14, 2025

RBC Capital Maintains Aardvark Therapeutics (AARD) Outperform Recommendation - Nasdaq

Nov 14, 2025

Nov 14, 2025

Cantor Fitzgerald reiterates Overweight rating on Aardvark Therapeutics stock By Investing.com - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

Stifel reiterates Buy rating on Aardvark Therapeutics stock, maintains $24 target - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

Cantor Fitzgerald reiterates Overweight rating on Aardvark Therapeutics stock - Investing.com

Nov 14, 2025

Nov 14, 2025

Can Aardvark Therapeutics Inc. stock deliver sustainable ROEMarket Performance Report & Verified Momentum Stock Watchlist - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Aardvark Therapeutics stock price target lowered to $18 at RBC Capital By Investing.com - Investing.com South Africa

Nov 14, 2025

Nov 14, 2025

Aardvark Therapeutics stock price target lowered to $18 at RBC Capital - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates - The Manila Times

Nov 14, 2025

Nov 13, 2025

Aardvark Therapeutics, Inc. SEC 10-Q Report - TradingView

Nov 13, 2025

Nov 13, 2025

Aardvark (Nasdaq: AARD) aligns with FDA to lower HERO trial age to 10, runway into 2027 - Stock Titan

Nov 13, 2025

Nov 12, 2025

Is Aardvark Therapeutics Inc. building a consolidation baseJuly 2025 Sentiment & High Accuracy Buy Signal Tips - newser.com

Nov 12, 2025

Nov 11, 2025

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Nov 11, 2025

Nov 11, 2025

Aardvark Therapeutics (NASDAQ: AARD) grants 4,881-share inducement option at $10.44 - Stock Titan

Nov 11, 2025

Nov 10, 2025

Aardvark Therapeutics, Inc.: Undervalued Potential in the Obesity Treatment Market with Promising Pipeline - TipRanks

Nov 10, 2025

Nov 10, 2025

Is Aardvark Therapeutics Inc. forming a bottoming basePortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com

Nov 10, 2025

Nov 09, 2025

Aardvark Therapeutics Showcases Obesity Research at ObesityWeek - MSN

Nov 09, 2025

Nov 09, 2025

Is Aardvark Therapeutics Inc. stock attractive for income investorsWeekly Risk Summary & Safe Capital Growth Stock Tips - newser.com

Nov 09, 2025